ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF

Title:

ANTIGENIC POLYPEPTIDES AND METHODS OF USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2021/016534

Kind Code:

A3

Abstract:

Provided are novel antigenic polypeptides comprising tumor-associated peptides, and compositions comprising the same. Such antigenic polypeptides and compositions are particularly useful as immunotherapeutics (e.g., cancer vaccines). Also provided are methods of inducing a cellular immune response using the polypeptides and compositions, methods of treating a disease using the polypeptides and compositions, kits comprising the polypeptides and compositions, methods of making the compositions, and antibodies and T cell receptors that specifically bind to the polypeptides.

More Like This:

JP2007524583	Peptides related to HLA-DRMHC class II molecules involved in autoimmune disorders
JP2008537736	Recombinant MHC molecule useful for manipulating antigen-specific T cells
JP2019070034	IMMUNOMODULATORY AGENTS AND USES THEREOF

Inventors:

UNDERWOOD DENNIS (US)
MYERS PAISLEY (US)
JEFFERY ERIN (US)
PEREZ MATTHEW (US)
MORIN BENJAMIN (US)
FINDEIS MARK (US)
JOSHI BISHNU (US)

Application Number:

PCT/US2020/043435

Publication Date:

March 04, 2021

Filing Date:

July 24, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

AGENUS INC (US)

International Classes:

C07K14/74; C07K7/06; C07K16/28

Domestic Patent References:

WO2003040165A2	2003-05-15
WO2010044952A2	2010-04-22
WO2015143228A1	2015-09-24

Foreign References:

US20160331821A1	2016-11-17
US20190048094A1	2019-02-14

Attorney, Agent or Firm:

WILKINS, Andrew (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: GENE EXPRESSION PROGRAMMING

Next Patent: LOW FREE 2-MERCAPTOETHANOL ESTER AND USES THEREOF